Drug intelligence / Profile preview

SETD8 shRNA

Development stage
Preclinical
Lead developer
Shandong University
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

SETD8 shRNA is a short hairpin RNA (shRNA) designed to silence the expression of the SETD8 gene (also known as KMT5A or PR-Set7). SETD8 is the sole methyltransferase responsible for the mono-methylation of histone H4 at lysine 20 (H4K20me1), an epigenetic mark associated with transcriptional activation and cell cycle regulation. In the context of Acute Myeloid Leukemia (AML), SETD8 knockdown via shRNA has been shown to inhibit cell proliferation and induce apoptosis by downregulating the expression of CXCR4, a critical receptor for leukemia cell survival and infiltration. This genetic intervention serves as a tool for validating SETD8 as a therapeutic target in hematological malignancies.

Other names
sh-SETD8sh-SETD-8sh-SETD 8SETD8 short hairpin RNASETD-8 short hairpin RNASETD 8 short hairpin RNA
02

Targets

SETD8 (Lysine methyltransferase 5A)

Beyond the preview

Go deeper on SETD8 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SETD8 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call